Zacks Investment Research on MSN
Organon secures FDA approval extending NEXPLANON use to five years
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
The birth control implant, brand name Nexplanon, is considered one of the most effective reversible contraceptive methods available. It provides protection from pregnancy for up to three years with a ...
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) ...
Nexplanon is a prescription drug used to help prevent pregnancy. Nexplanon can cause mild to severe side effects, such as weight gain, nausea, and changes in period bleeding. Nexplanon is used to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback